Amgen Balance Sheet Health
Financial Health criteria checks 2/6
Amgen has a total shareholder equity of $6.8B and total debt of $61.5B, which brings its debt-to-equity ratio to 907.6%. Its total assets and total liabilities are $90.3B and $83.5B respectively. Amgen's EBIT is $10.2B making its interest coverage ratio 4.9. It has cash and short-term investments of $34.2B.
Key information
907.6%
Debt to equity ratio
US$61.54b
Debt
| Interest coverage ratio | 4.9x |
| Cash | US$34.25b |
| Equity | US$6.78b |
| Total liabilities | US$83.49b |
| Total assets | US$90.27b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1AMGN's short term assets ($47.4B) exceed its short term liabilities ($17.1B).
Long Term Liabilities: 1AMGN's short term assets ($47.4B) do not cover its long term liabilities ($66.4B).
Debt to Equity History and Analysis
Debt Level: 1AMGN's net debt to equity ratio (402.5%) is considered high.
Reducing Debt: 1AMGN's debt to equity ratio has increased from 231.4% to 907.6% over the past 5 years.
Debt Coverage: 1AMGN's debt is not well covered by operating cash flow (17.5%).
Interest Coverage: 1AMGN's interest payments on its debt are well covered by EBIT (4.9x coverage).